1. Home
  2. BCYC

BCYC

Bicycle Therapeutics plc

Logo Bicycle Therapeutics plc

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 3:32pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Founded: N/A Country:
United Kingdom
United Kingdom
Employees: N/A City: CAMBRIDGE
Market Cap: 844.7M IPO Year: 2019
Target Price: $48.11 AVG Volume (30 days): 391.7K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.08 EPS Growth: N/A
52 Week Low/High: $12.54 - $28.91 Next Earning Date: 05-02-2024
Revenue: $26,976,000 Revenue Growth: 86.52%
Revenue Growth (this year): 3.92% Revenue Growth (next year): -13.84%

Share on Social Networks: